MX2010001187A - Modulators of ccr9 receptor and methods of use thereof. - Google Patents
Modulators of ccr9 receptor and methods of use thereof.Info
- Publication number
- MX2010001187A MX2010001187A MX2010001187A MX2010001187A MX2010001187A MX 2010001187 A MX2010001187 A MX 2010001187A MX 2010001187 A MX2010001187 A MX 2010001187A MX 2010001187 A MX2010001187 A MX 2010001187A MX 2010001187 A MX2010001187 A MX 2010001187A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- modulators
- ccr9 receptor
- compounds
- ccr9
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
Provided are compounds that are modulators of CCR9 receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, provided are methods for treating or ameliorating diseases associated with modulation of CCR9 receptor activity.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96264007P | 2007-07-30 | 2007-07-30 | |
PCT/US2008/009142 WO2009017719A2 (en) | 2007-07-30 | 2008-07-28 | Modulators of ccr9 receptor and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010001187A true MX2010001187A (en) | 2010-03-04 |
Family
ID=40305125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010001187A MX2010001187A (en) | 2007-07-30 | 2008-07-28 | Modulators of ccr9 receptor and methods of use thereof. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2220065A2 (en) |
KR (1) | KR20100033418A (en) |
AU (1) | AU2008282903B2 (en) |
CA (1) | CA2692013C (en) |
MX (1) | MX2010001187A (en) |
SG (1) | SG183667A1 (en) |
WO (1) | WO2009017719A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2385938T3 (en) | 2009-01-12 | 2015-07-31 | Pfizer Ltd | Sulfonamide derivatives |
JP2013525368A (en) * | 2010-04-23 | 2013-06-20 | キネタ・インコーポレイテツド | Antiviral compounds |
CA2804173C (en) | 2010-07-09 | 2015-01-13 | Pfizer Limited | Sulfonamide nav1.7 inhibitors |
US9221787B2 (en) * | 2010-10-12 | 2015-12-29 | Zafgen, Inc. | Sulphonamine compounds and methods of making and using same |
TW201512171A (en) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | Chemical compounds |
WO2023074408A1 (en) * | 2021-10-28 | 2023-05-04 | 四国化成工業株式会社 | Thiophene compound, method for synthesizing same, and composition containing said thiophene compound |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69718038D1 (en) * | 1996-10-16 | 2003-01-30 | American Cyanamid Co | PRODUCTION AND USE OF ORTHO-SULFONAMIDO-HETEROARYLHYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS |
JP3972163B2 (en) * | 1999-06-18 | 2007-09-05 | 株式会社大塚製薬工場 | Phosphonic acid diester derivatives |
EP1610753A4 (en) * | 2003-02-20 | 2007-07-04 | Encysive Pharmaceuticals Inc | Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
-
2008
- 2008-07-28 KR KR1020107001995A patent/KR20100033418A/en not_active Application Discontinuation
- 2008-07-28 CA CA2692013A patent/CA2692013C/en not_active Expired - Fee Related
- 2008-07-28 EP EP08794832A patent/EP2220065A2/en not_active Withdrawn
- 2008-07-28 SG SG2012056255A patent/SG183667A1/en unknown
- 2008-07-28 MX MX2010001187A patent/MX2010001187A/en not_active Application Discontinuation
- 2008-07-28 WO PCT/US2008/009142 patent/WO2009017719A2/en active Application Filing
- 2008-07-28 AU AU2008282903A patent/AU2008282903B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2009017719A2 (en) | 2009-02-05 |
AU2008282903A1 (en) | 2009-02-05 |
AU2008282903B2 (en) | 2011-06-30 |
KR20100033418A (en) | 2010-03-29 |
WO2009017719A8 (en) | 2010-02-11 |
CA2692013C (en) | 2012-08-28 |
WO2009017719A3 (en) | 2009-04-23 |
CA2692013A1 (en) | 2009-02-05 |
SG183667A1 (en) | 2012-09-27 |
EP2220065A2 (en) | 2010-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301145I1 (en) | ||
MX2009006812A (en) | Modulators of c3a receptor and methods of use thereof. | |
PH12020550450A1 (en) | Certain chemical entities, compositions and methods | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
PL2134704T3 (en) | Compounds and compositions as modulators of gpr119 activity | |
EA201001329A1 (en) | COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS | |
EP2542254A4 (en) | Secondary structure stabilized nmda receptor modulators and uses thereof | |
TW200716624A (en) | Compounds for modulating TRPV3 function | |
MY159955A (en) | Certain chemical entities, compositions and methods | |
TW200801021A (en) | Imidazolothiazole compounds for the treatment of disease | |
WO2009044173A3 (en) | Methods of treating cancer using notch pathway inhibitors | |
EA201001332A1 (en) | COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS | |
UA98629C2 (en) | Compounds and methods for kinase modulation | |
MX2011006150A (en) | Kinase inhibitor compounds. | |
EA201001330A1 (en) | COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS | |
MX2007010560A (en) | Roflumilast for the treatment of diabetes mellitus. | |
MX2012004078A (en) | Compounds and compositions as modulators of gpr119 activity. | |
MX2010002028A (en) | Methods and compositions for modulating t cells. | |
MX2020008106A (en) | Spiro-lactam nmda receptor modulators and uses thereof. | |
MX2010001187A (en) | Modulators of ccr9 receptor and methods of use thereof. | |
HK1155943A1 (en) | Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders | |
IN2012DN03844A (en) | ||
MY157007A (en) | Novel possibility of controlling giardiosis | |
AU316238S (en) | Lawning applicator for microbiological cultures | |
DE602006018461D1 (en) | GALK1S AS PTEN / ACT WAY MODIFICATORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |